Resources
BNET Resources
- sort by:
- Relevance
- Date
- Popularity
- Bothell, Wash.-Based Nastech Pharmaceutical Gets Impotence-Drug Rights, Cash.
- By Luke Timmerman, The Seattle Times Knight Ridder/Tribune Business News Jan. 28--Nastech Pharmaceutical has snapped up full rights to its experimental nasal-spray drug for impotence and, in an unusual twist, has been handed $13.5 million to take it from drug giant Pharmacia. ...
- Research articles 2003-01-28
- Pharmacia Takes It Global
- One company's success demonstrates that there's hope for building truly integrated worldwide communications teams. Although pharma company communicators understand the complex global network of healthcare information available to consumers, they must still deal with the regionalization of healthcare delivery. They increasingly face the challenge of delivering locally relevant information...
- White papers 2003-04-01
- Elan's Pennsylvania Lawyer Once Again Makes News
- The pressure on Elan Pharmaceuticals CEO Kelly Martin to resign is increasing. Crabtree Partners, an investment company, sent a letter to Elan's board calling for the termination of Martin. But an interesting side-note in this soap opera is the history of Elan's general counsel, Richard Collier. Crabtree...
- Blog posts 2008-12-15
- Pfizer Faces $21 Billion in Fines for Pharmacia's Crimes; 32 Other Companies on the Hook
- A jury verdict in Wisconsin could expose Pfizer to up to $21 billion in fines after the company was found guilty of gaming Medicaid. It will likely prompt a wave of settlements from other drug companies that are on the hook in this raft of cases. Pfizer,...
- Blog posts 2009-02-18
Additional Resources
- Hershey Foods Corporation and Pharmacia Corporation announced that they have completed a transaction for the sale of Hershey's Luden's throat drops business to Pharmacia Consumer Healthcare, a unit of Pharmacia Corporation - Brief Article
- Hershey Foods Corporation and Pharmacia Corporation announced that they have completed a transaction for the sale of Hershey's Luden's throat drops business to Pharmacia Consumer Healthcare, a unit of Pharmacia Corporation. Included in the transaction, terms of which were not disclosed, are the trademarks and manufacturing equipment for the business.
- Research articles 2001-09-10
- MIGLITOL.(Pharmacia & Upjohn purchases product marketing rights from Bayer AG and Bayer Corp.)
- MIGLITOL-Pharmacia & Upjohn is acquiring Bayer AG's and Bayer Corporation s marketing rights to miglitol in the US, Canada, Australia and New Zealand. Pharmacia & Upjohn will market the ... MIGLITOL-Pharmacia & Upjohn is acquiring Bayer AG's and Bayer Corporation s marketing rights to miglitol in...
- Research articles 1998-09-07
- 2 Execs depart: Pfizer gives dose of consolidation to Pharmacia.(News)
- Byline: Phyllis Feinberg NEW YORK - Pfizer Inc. is cleaning house at the pension fund of Pharmacia Corp., eliminating the jobs of the top two executives responsible for running the Pharmacia fund and doing a review of the external asset managers f Byline:...
- Research articles 2003-05-12
- Amersham Pharmacia Biotech Fulfills Merger Potential.(Company Financial Information)
- IN ITS FIRST FULL YEAR of operation, Amersham Pharmacia Biotech AP Biotech, the joint venture created by the August 1997 merger of the life science businesses of Nycomed Amersham PLC and Pharmacia & Upjohn Inc. (P&U), enjoyed robust growt IN ITS FIRST FULL YEAR...
- Research articles 1999-05-10
- Monsanto And Pharmacia & Upjohn File Preliminary Proxy Statement To Form Combined New Company - Pharmacia Corporation
- Monsanto Company (NYSE: MTC) and Pharmacia & Upjohn, Inc. (NYSE: PNU) today announced the filing of a preliminary joint proxy statement with the U.S. Securities and Exchange Commission detailing the proposed merger between the two companies to create a combined new company named Pharmacia...
- Research articles 1970-01-01
- PDT Inc. and Pharmacia sign supply agreements
- SANTA BARBARA, Calif.--BUSINESS WIRE--Sept. 13, 1995--PDT Inc. (NASDAQ:PDTI) and Pharmacia S.p.A., Italian subsidiary of Pharmacia AB (NASDAQ:PHARY), Wednesday signed two supply contracts that support the recent license agreement under which Pharmacia acquired the rights to PDT's leading drug, tin ethyl etiopurpurin (SnET2).The first agreement specifies the terms under which PDT...
- Research articles 1995-09-13
- KEEPING THE BEST: Pfizer fund not likely to bulldoze Pharmacia after acquisition.(Pfizer Inc. purchase of Pharmacia Corp.)(Brief Article)(Statistical Data Included)
- NEW YORK - If history is any guide, the combined pension fund that results from the proposed Pfizer Inc. acquisition of Pharmacia Corp. may not mirror Pfizer's current $3.3 billion defined benefit plan. Pfizer's $60 billion deal to acquire Peapack, NEW YORK - If...
- Research articles 2002-08-19
- Stock Watch: Pfizer's other strategy; Pharmacia buy gets headlines, but company invests in hundreds of firms.(Pfizer Inc. acquires Pharmacia Corp.)(Brief Article)
- Pfizer inc.'s $53 billion acquisition of Pharmacia Corp. grabbed the headlines last week, but acquiring other companies is only one of the drugmaker's strategies for growth. For years, the giant pharmaceutical company has gone outside its own labs Pfizer inc.'s $53 billion acquisition...
- Research articles 2002-07-22
- PHARMACIA & UPJOHN.(Pharmacia and Upjohn Inc. obtain FDA approval for Camptosar Injection )(Business Brief)(Brief Article)(Product Announcement)
- PHARMACIA & UPJOHN has reccived full marketing approval from FDA for Camptosar Injection irinotecan hydrochloride injection for metastatic colorectal cancer. Camptosar ... PHARMACIA & UPJOHN has reccived full marketing approval from FDA for Camptosar Injection irinotecan hydrochloride injection for metastatic colorectal cancer. Camptosar...
- Research articles 1998-11-02
- Monsanto and P&U Shareholders Okay Deal.(Monsanto and Pharmacia & Upjohn merger)(Brief Article)
- SHAREHOLDERS OF both Monsanto Company and Pharmacia & Upjohn have approved the proposed merger of the two companies. The merger is expected to close on or before April 1. The new company, ... SHAREHOLDERS OF both Monsanto Company and...
- Research articles 2000-03-27
- Monsanto, Pharmacia to Assess Kanawha River Dioxins
- PHILADELPHIA, Pennsylvania ENS ? Monsanto Company and Pharmacia Corporation have agreed to investigate dioxin contamination of the Kanawha River primarily associated with operations at an old Monsanto plant, now owned by Flexsys, in Nitro, West Virginia. Pharmacia is the former parent corporation of Monsanto. The companies entered into an...
- Research articles 2004-03-23
- AMERSHAM PHARMACIA BIOTECH: DNA sequencer first ca capillary-based instrument to gain PHRED validation.
- M2 PRESSWIRE-6 September 1999-AMERSHAM PHARMACIA BIOTECH: Amersham Pharmacia Biotech's DNA sequencer becomes first capillary-based instrument to achieve validation with PHRED C1994-99 M2 COMMUNICATIONS LTD RDATE:030999 * "The community can be confident in using data generated by MegaBACE" ...
- Research articles 1999-09-06
- Pharmacia Files for Monsanto IPO.(inital public offering)(Brief Article)(Statistical Data Included)
- PHARMACIA HAS FILED A REGISTRATION statement with the Securities and Exchange Commission SEC for an initial public offering IPO of 19.9% of its Monsanto agricultural and biotechnology businesses. Pharmacia, the company formed last year from the merger of Pharmacia & Upjohn and Monsanto, will hold the...
- Research articles 2000-05-24
- Amersham Pharmacia Biotech to Go Public
- London, UK 8/7/00-Nycomed Amersham plc announced that is will take 10% of its shares of Amersham Pharmacia Biotech AP Bio public later this year on the NASDAQ stock exchange. Nycomed Amersham owns 55% of AP Bio, and Pharmacia owns 45% of the company. Nycomed Amersham will control the...
- Research articles 2000-08-15
- DepoTech Corp. Reports Second-Quarter 1997 Financial Results and Receipt of Initial Payment from Pharmacia & Upjohn
- SAN DIEGO--BUSINESS WIRE--July 15, 1997--DepoTech Corp. (NASDAQ:DEPO) Tuesday reported financial results for the second quarter ended June 30, 1997. Additionally, the company announced the receipt of an initial payment of $2 million from Pharmacia & Upjohn S.p.A., an affiliate of Pharmacia & Upjohn Inc., upon the signing...
- Research articles 1997-07-15
- Biotech Supply Giant Unveils New Logo; Amersham Pharmacia Biotech Retains, Updates Classic Droplet Image
- UPPSALA, Sweden--BUSINESS WIRE--November 3, 1997--Amersham Pharmacia Biotech, the company formed earlier this year with the merger of Amersham Life Science and Pharmacia Biotech, today unveiled its new corporate logo. The world's largest research-based biotechnology supply company has retained the widely recognized "droplet" image, first created for Pharmacia Biotech...
- Research articles 2002-11-01
- << Previous
- page 1 of 1
- Next >>
